Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 10/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3844352 | 0.94 | PPARA (0.48) | PPARAPPARGPPARDADORA3CNR1 | |
| SCHEMBL3844402 | 0.93 | PPARA (0.38) | PPARAPPARGPPARDCNR1LMNA | |
| SCHEMBL3841977 | 0.92 | PPARA (0.54) | PPARAPPARGPPARDADORA3 | |
| SCHEMBL3841464 | 0.91 | PPARA (0.48) | PPARAPPARGPPARDADORA3LMNA | |
| SCHEMBL3844298 | 0.90 | PPARA (0.51) | PPARAPPARGPPARDADORA3CNR1 | |
| SCHEMBL3845277 | 0.90 | PPARA (0.45) | PPARAPPARGPPARDADORA3CNR1 | |
| SCHEMBL3840771 | 0.90 | PPARA (0.45) | PPARAPPARGPPARDADORA3CNR1 | |
| SCHEMBL3848279 | 0.89 | PPARA (0.47) | PPARAPPARGPPARDADORA3CNR1 | |
| SCHEMBL3841039 | 0.89 | PPARA (0.39) | PPARAPPARGPPARDLMNAMAPT | |
| SCHEMBL3844887 | 0.88 | PPARA (0.52) | PPARAPPARGPPARDADORA3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1856065-B1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PF MEDICAMENT (FR) | 2009-11-11 | — | — | EP | claimed |